Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 1 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 361Lung Neoplasms 195Breast Neoplasms 163Ovarian Neoplasms 129Triple Negative Breast Neoplasms 79Squamous Cell Carcinoma of Head and Neck 73Small Cell Lung Carcinoma 67Fallopian Tube Neoplasms 56Head and Neck Neoplasms 46Carcinoma, Ovarian Epithelial 44Neoplasms 40Neoplasm Metastasis 39Esophageal Neoplasms 36Adenocarcinoma of Lung 36Esophageal Squamous Cell Carcinoma 29Prostatic Neoplasms 27Endometrial Neoplasms 27Uterine Cervical Neoplasms 23Brain Neoplasms 23Central Nervous System Neoplasms 22Urinary Bladder Neoplasms 21Carcinoma, Squamous Cell 21Recurrence 20Neuroblastoma 20Lymphoma, Large B-Cell, Diffuse 20Melanoma 19Lymphoma 19Carcinoma 19Adenocarcinoma, Bronchiolo-Alveolar 18Testicular Neoplasms 15

Interventions

Nivolumab 5olaparib 3Specimen Handling 3Paclitaxel 3durvalumab 2cediranib 2Magnetic Resonance Spectroscopy 2Carboplatin 2Biopsy 2rucaparib 1pazopanib 1pamiparib 1liposomal doxorubicin 1ceralasertib 1capivasertib 1cabozantinib 1apatinib 1Trabectedin 1Ipilimumab 1Immunoglobulin G 1Gemcitabine 1Fluid Therapy 1Disulfides 1Cisplatin 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Carcinosarcoma × Carboplatin × Clear all
NCT00815945 2017-02-14

Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors

AGO Study Group

Phase 2 Completed
41 enrolled
Sarcoma

Carcinosarcoma, Leiomyosarcoma

NCT00505492 2011-09-15

Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/Chemotherapy

M.D. Anderson Cancer Center

Phase 2 Terminated
4 enrolled
GynecologicSarcoma

Carcinosarcoma, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡